Serial #90273164
DEAD

Serial Number

90273164

Owner

Platelet BioGenesis Inc.

Attorney

Roman Fayerberg

Filing Date

Oct 23, 2020

Add to watchlist:

No watchlists yet
View on USPTO

Serial #90273164 Trademark

Serial Number: 90273164

Serial #90273164 is a trademark filed by Platelet BioGenesis Inc. on October 23, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Platelet BioGenesis Inc. (7 trademarks)

Watertown, MA 02472

Entity Type: 03

Trademark Details

Filing Date

October 23, 2020

Registration Date

Not Registered

Published for Opposition

January 18, 2022

Goods & Services

Platelets that are not bone marrow-derived, platelet variants, megakaryocytes, megakaryocytes variants, and products derived from platelets, megakaryocytes or their variants, and admixtures, namely, extracellular vesicles or exosomes, all the foregoing for medical or clinical use; platelet variants for medical or clinical use; pharmaceutical and drug delivery compositions comprising platelet variants for the treatment of tumors, immune-oncology, hematology, cardiovascular, inflammatory, immune and autoimmune diseases, conditions, or responses, critical care disorders, conditions and injuries, solid organ transplantation, wound healing, neurological disorders and orthopedics; Pharmaceutical compositions for drug delivery comprising non bone marrow-derived platelets, platelet variants for treatment of tumors, immune-oncology, hematology, cardiovascular, inflammatory, immune and autoimmune diseases, conditions, or responses, critical care disorders, conditions and injuries, solid organ transplantation, wound healing, neurological disorders and orthopedics; pharmaceutical compositions comprising platelet variants for transfusion in oncology, trauma and surgery; platelet variants for delivering proteins, antibodies, nucleic acids and other drugs to tumors, sites of vascular injury and inflammation, immune-oncology, hematology, cardiovascular, inflammatory, immune and autoimmune diseases, conditions, or responses, critical care disorders, conditions and injuries, solid organ transplantation, wound healing, neurological disorders and orthopedics; platelet variants for the treatment of tumors, immune-oncology, hematology, cardiovascular, inflammatory, immune and autoimmune diseases, conditions, or responses, critical care disorders, conditions and injuries, solid organ transplantation, wound healing, neurological disorders, and orthopedics; platelet variants as source for growth factors for medical or clinical use; compositions comprising viral vectors for medical or clinical use

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Apr 17, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Apr 17, 2023 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 15, 2022 EXRA
SOU EXTENSION 1 GRANTED
Sep 13, 2022 EX1G
SOU EXTENSION 1 FILED
Sep 13, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 13, 2022 EEXT
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 24, 2022 CHAN
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 11, 2022 AITU
TEAS POST PUBLICATION AMENDMENT RECEIVED
Apr 6, 2022 EPPA
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 15, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 18, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jan 18, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 29, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 15, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 9, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 8, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 8, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 8, 2021 GNRN
NON-FINAL ACTION E-MAILED
Apr 8, 2021 GNRT
NON-FINAL ACTION WRITTEN
Apr 8, 2021 CNRT
ASSIGNED TO EXAMINER
Mar 24, 2021 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Dec 12, 2020 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 11, 2020 NWOS
NEW APPLICATION ENTERED
Oct 27, 2020 NWAP